ChAd63-KH

N/A

Report date: 2022/11/27 16:45:05

Base Information

Drug NameChAd63-KH
Drug Alias NameChAd63-KH
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLeishmaniasis, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySudan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of York
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of York
Inactive CompaniesN/A
Active IndicationsLeishmaniasis, Cutaneous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A